{"altmetric_id":9933798,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["GoToPER"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4e83cf058f610002280","authors":["Al-Ahmadie, Hikmat"],"doi":"10.1093\/annonc\/mdw268","first_seen_on":"2016-07-21T23:54:56+00:00","funders":["niehs"],"issns":["1569-8041","0923-7534"],"journal":"Annals of Oncology","last_mentioned_on":1469145279,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27436847?dopt=Abstract&utm_medium=twitter"],"pmid":"27436847","pubdate":"2016-07-19T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"mdw268","subjects":["neoplasms"],"title":"PD-L1 expression in penile cancer: A new frontier for immune checkpoint inhibitors?","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/pdl1-expression-penile-cancer-new-frontier-immune-checkpoint-inhibitors"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":8088508,"mean":6.8823654995833,"rank":6142869,"this_scored_higher_than_pct":13,"this_scored_higher_than":1085813,"rank_type":"exact","sample_size":8088508,"percentile":13},"similar_age_3m":{"total_number_of_other_articles":258114,"mean":11.985157431047,"rank":182771,"this_scored_higher_than_pct":15,"this_scored_higher_than":40008,"rank_type":"exact","sample_size":258114,"percentile":15},"this_journal":{"total_number_of_other_articles":3584,"mean":9.5105073960368,"rank":2895,"this_scored_higher_than_pct":11,"this_scored_higher_than":401,"rank_type":"exact","sample_size":3584,"percentile":11},"similar_age_this_journal_3m":{"total_number_of_other_articles":98,"mean":24.134618556701,"rank":86,"this_scored_higher_than_pct":3,"this_scored_higher_than":3,"rank_type":"exact","sample_size":98,"percentile":3}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Other":1,"Researcher":1},"by_discipline":{"Medicine and Dentistry":2}}},"geo":{"twitter":{"US":1},"mendeley":{"JP":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/GoToPER\/statuses\/756276231893495808","license":"gnip","citation_ids":[9933798],"posted_on":"2016-07-21T23:54:39+00:00","author":{"name":"PER","url":"http:\/\/gotoper.com","image":"https:\/\/pbs.twimg.com\/profile_images\/3438723869\/2416df847bccb4c5ad8da6015ba30370_normal.jpeg","description":"Physicians' Education Resource (PER) specializes in oncology and hematology CME-certified activities. We advance cancer care through professional education.","id_on_source":"GoToPER","tweeter_id":"37703552","geo":{"lt":40.31622,"ln":-74.51376,"country":"US"},"followers":4420},"tweet_id":"756276231893495808"}]}}